Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: A retrospective, multicentre case series

CNS Drugs

Volumn 24, Issue 11, 2010, Pages 969-976

  Fragoso, Yára D ^a   Finkelsztejn, Alessandro ^b   Kaimen Maciel, Damacio R ^c   Grzesiuk, Anderson K ^d   Gallina, Andre S ^e   Lopes, Josiane ^c   Morales, Nivea M O ^f   Alves Leon, Soniza V ^g   De Almeida, Sandra M G ^h  

^a UNIVERSIDADE METROPOLITANA DE SANTOS   (Brazil)

^b Hospital de Clnicas de Porto Alegre   (Brazil)

^c STATE UNIVERSITY OF LONDRINA   (Brazil)

^d Centro de Reabilitacao Integral Dom Aquino Correa   (Brazil)

^e Piracicaba ^*  (Brazil)

^f FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^g FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^h FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

Glatiramer acetate, adverse reactions; Glatiramer acetate, therapeutic use; Immunomodulators, adverse reactions; Immunomodulators, therapeutic use; Multiple sclerosis; Pregnancy; Teratogenesis

Indexed keywords

BETA1A INTERFERON; CORTICOSTEROID; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONGENITAL MALFORMATION; DENVER DEVELOPMENTAL SCREENING TEST; DEVELOPMENTAL DISORDER; DRUG WITHDRAWAL; FEMALE; HUMAN; LONG TERM CARE; MALE; MULTIPLE SCLEROSIS; NEWBORN; OUTPATIENT; PERINATAL PERIOD; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; RELAPSE; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; TREATMENT DURATION; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; PEPTIDES; PREGNANCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957850617     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11538960-000000000-00000     Document Type: Article

References (19)

1. Confravreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998 Jul 30; 339 (5): 283-91
2. Medical Corps™. Pregnancy categories [online]. Available from URL: http://www.medicalcorps.com/pharmacy/Preg nancyCategories.htm [Accessed 2010 Apr 23]
3. Perinatology.com. FDA use-in-pregnancy ratings [online]. Available from URL: http://www.perinatology.com/expo sures/Drugs/FDACategories.htm [Accessed 2010 Apr 23]
4. Ringel I, Zettl UK. Intravenous immunoglobulin therapy in neurological diseases during pregnancy. J Neurol 2006; 253 Suppl. 5: V70-4
5. Achiron A, Kishner I, Doley M, et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 2004 Sep; 251 (9): 1133-7
6. Haas J, Hommes OR. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Mult Scler 2007 Aug; 13 (7): 900-8
7. Fazekas F, Strasser-Fuchs S, Hommes OR. Intravenous immunoglobulin in MS: promise or failure? J Neurol Sci 2007 Aug 15; 259 (1-2): 61-6
8. Dudesek A, Zettl UK. Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis. J Neurol 2006 Sep; 253 Suppl. 5: V50-8
9. Fragoso YD, Finkelsztejn A, Comini-Frota ER, et al. Pregnancy and multiple sclerosis: the initial results from a Brazilian database. Arq Neuropsiquiatr 2009 Sep; 67 (3A): 657-60
10. Weber-Schoendorfer C, Schaefer C. Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult Scler 2009 Sep; 15 (9): 1037-42
11. Salminen HJ, Leggett H, Boggild M.Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol. Epub 2010 Jul 13
12. Ministerio de Saude [online]. Available from URL: http://portal.saude. gov.br/portal/saude/default.cfm [Accessed 2010 Apr 23]
13. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50 (1): 121-7
14. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology (Cleveland) 1983; 33 (1): 1444-52
15. Frankenburg WK, Dodds J, Archer P, et al. The Denver II: a major revision and restandardization of the Denver Developmental Screening Test. Pediatrics 1992 Jan; 89: 91-7
16. Behague DP, Victora CG, Barros FC. Consumer demand for caesarean sections in Brazil: informed decision making, patient choice, or social inequality? BMJ 2002; 324 (7343): 942
17. Wenzel D, Ocana-Riola R, Maroto-Navarro G, et al. A multilevel model for the study of breast-feeding determinants in Brazil. Maternal Child Nutr. Epub 2009 Aug 25
18. Langer-Gould A, Huang SM, Gupta R, et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 2009; 66 (8): 958-63
19. Chen M, Gran B, Costello K, et al. Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS. Mult Scler 2001 Aug 1; 7 (4): 209-19